Revance and Teoxane announce that RHA® Dynamic Volume, formerly RHA® 4 Mepi, is now available. RHA® Dynamic Volume is a product designed with unique rheology to adapt to facial movements and deliver natural-looking results. As aesthetic medicine continues to evolve, patients increasingly seek treatments that enhance natural beauty.
Now FDA-approved for cheek augmentation and/or age-related midface contour deficiencies, RHA® Dynamic Volume offers providers the option to address volume loss by restoring both dynamic superficial fat, which moves with facial expressions, and/or static deep fat, which provides foundational support, for up to one year. Additionally, weight loss medications can induce facial fat loss leading many to seek natural-looking restoration of facial volume.
“RHA® Dynamic Volume represents the next chapter of the Teoxane RHA® Collection,” shared Nadeem Moiz, CEO of Revance. “This launch underscores the product’s ability to meet the growing demand for fillers that deliver natural-looking, dynamic results. With the expanded midface indication, RHA® Dynamic Volume continues to set the standard for facial rejuvenation by combining adaptability, resiliency, and long-lasting results.”
Using Teoxane’s ATP approach (Anatomy, Assessment & Aging, Technique, Product) and the Teoxane MLT Multilayering Technique™, providers can achieve precise, tailored results while prioritizing safety by avoiding high-risk vascular zones. RHA® Dynamic Volume, paired with the Teoxane MLT Multilayering Technique™, addresses midface volume loss by restoring deep structural support and enhancing superficial dynamic contours, delivering tailored, natural-looking results.
“RHA® Dynamic Volume represents a strong demonstration of our commitment to uniting advanced technology, scientific excellence, and a truly patient‑centered approach to facial rejuvenation,” said Can Ongen, COO at Teoxane. “When combined with Teoxane’s MLT Multilayering Technique™, RHA® Dynamic Volume provides natural‑looking midface results that align with the expectations of today’s aesthetic patients.”
Patient satisfaction data further demonstrates the effectiveness of RHA® Dynamic Volume. In clinical studies, approximately 98% of patients reported natural-looking results in the midface at 2 months, while over 94% reported natural-feeling results at rest and in motion at 1 year.2 In clinical trials, RHA® Dynamic Volume demonstrated a favorable safety profile, with no late-onset or serious treatment-related adverse events, and no events deemed to be granulomas or delayed inflammatory responses.
“RHA® Dynamic Volume is an innovation for patients experiencing volume loss due to weight changes or aging in the midface, delivering results that are beautiful at rest and in motion,” said board-certified dermatologist Dr. Jody Comstock. “It’s a versatile option that allows me to tailor treatments to each patient’s unique needs.”
